MARIA JULIA BARISON

Dr. MARIA JULIA BARISON

Basic Stem Cell Biology Laboratory, Instituto Carlos Chagas - FIOCRUZ-PR
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MBMARIA JULIA BARISON
MARIA JULIA BARISON
LRLudmila Nakamura Rapado
Ludmila Nakamura Rapado
EMEmilio F. Merino
Emilio F. Merino
EPElizabeth Mieko Furusho Pral
Elizabeth Mieko Furusho Pral
BMBrian Suarez Mantilla
Brian Suarez Mantilla
MCMaria Belen Cassera
Maria Belen Cassera
Trypanosoma cruzi, the etiological agent of Chagas disease, is a protozoan parasite with a complex life cycle involving a triatomine insect and mammals. Throughout its life cycle, the T. cruzi parasite faces several alternating events of cell division and cell differentiation in which exponential and stationary growth phases play key biological roles. It is well accepted that arrest of the cell division in the epimastigote stage, both in the midgut of the triatomine insect and in vitro, is required for metacyclogenesis, and it has been previously shown that the parasites change the expression profile of several proteins when entering this quiescent stage. However, little is known about the metabolic changes that epimastigotes undergo before they develop into the metacyclic trypomastigote stage. We applied targeted metabolomics to measure the metabolic intermediates in the most relevant pathways for energy metabolism and oxidative imbalance in exponentially growing and stationary growth-arrested epimastigote parasites. We show for the first time that T. cruzi epimastigotes transitioning from the exponential to the stationary phase exhibit a finely tuned adaptive metabolic mechanism that enables switching from glucose to amino acid consumption, which is more abundant in the stationary phase. This metabolic plasticity appears to be crucial for survival of the T. cruzi parasite in the myriad different environmental conditions to which it is exposed during its life cycle.

15 August 2018 in Genes
Verified
Journal Article
Open access
PDF file
CACarla Cristi Del Campo Avila
Carla Cristi Del Campo Avila
SMSimon Ngao Mule
Simon Ngao Mule
LRLivia Rosa-Fernandes
Livia Rosa-Fernandes
RVRosa Viner
Rosa Viner
MBMARIA JULIA BARISON
MARIA JULIA BARISON
Giuseppe PalmisanoGiuseppe Palmisano
Giuseppe Palmisano
Trypanosoma cruzi, the etiologic agent of Chagas disease, cycles through different life stages characterized by defined molecular traits associated with the proliferative or differentiation state. In particular, T. cruzi epimastigotes are the replicative forms that colonize the intestine of the Triatomine insect vector before entering the stationary phase that is crucial for differentiation into metacyclic trypomastigotes, which are the infective forms of mammalian hosts. The transition from proliferative exponential phase to quiescent stationary phase represents an important step that recapitulates the early molecular events of metacyclogenesis, opening new possibilities for understanding this process. In this study, we report a quantitative shotgun proteomic analysis of the T. cruzi epimastigote in the exponential and stationary growth phases. More than 3000 proteins were detected and quantified, highlighting the regulation of proteins involved in different subcellular compartments. Ribosomal proteins were upregulated in the exponential phase, supporting the higher replication rate of this growth phase. Autophagy-related proteins were upregulated in the stationary growth phase, indicating the onset of the metacyclogenesis process. Moreover, this study reports the regulation of N-terminally acetylated proteins during growth phase transitioning, adding a new layer of regulation to this process. Taken together, this study reports a proteome-wide rewiring during T. cruzi transit from the replicative exponential phase to the stationary growth phase, which is the preparatory phase for differentiation.

1 July 2011 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
LPLisvane Silva Paes
Lisvane Silva Paes
BMBrian Suarez Mantilla
Brian Suarez Mantilla
MBMARIA JULIA BARISON
MARIA JULIA BARISON
CWCarsten Wrenger
Carsten Wrenger
ASAriel Mariano Silber
Ariel Mariano Silber
Trypanosoma cruzi is the causative agent of Chagas disease, which affects some 8 - 10 million people in the Americas. The only two drugs approved for the etiological treatment of the disease in humans were launched more than 40 years ago and have serious drawbacks. In the present work, we revisit the unique characteristics of T. cruzi mitochondria and mitochondrial metabolism. The possibility of taking advantage of these peculiarities to target new drugs against this parasite is also discussed.

24 May 2016 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
MBMARIA JULIA BARISON
MARIA JULIA BARISON
FDF. S. Damasceno
F. S. Damasceno
BMB. S. Mantilla
B. S. Mantilla
ASAriel Mariano Silber
Ariel Mariano Silber

10 January 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MCMarcell Crispim
Marcell Crispim
FDFlávia Silva Damasceno
Flávia Silva Damasceno
Agustin HernándezAgustin Hernández
Agustin Hernández
MBMARIA JULIA BARISON
MARIA JULIA BARISON
ISIsmael Pretto Sauter
Ismael Pretto Sauter
ASAriel Mariano Silber
Ariel Mariano Silber
Trypanosoma cruzi, the etiological agent of Chagas disease, consumes glucose and amino acids depending on the environmental availability of each nutrient during its complex life cycle. For example, amino acids are the major energy and carbon sources in the intracellular stages of the T. cruzi parasite, but their consumption produces an accumulation of NH4+ in the environment, which is toxic. These parasites do not have a functional urea cycle to secrete excess nitrogen as low-toxicity waste. Glutamine synthetase (GS) plays a central role in regulating the carbon/nitrogen balance in the metabolism of most living organisms. We show here that the gene TcGS from T. cruzi encodes a functional glutamine synthetase; it can complement a defect in the GLN1 gene from Saccharomyces cerevisiae and utilizes ATP, glutamate and ammonium to yield glutamine in vitro. Overall, its kinetic characteristics are similar to other eukaryotic enzymes, and it is dependent on divalent cations. Its cytosolic/mitochondrial localization was confirmed by immunofluorescence. Inhibition by Methionine sulfoximine revealed that GS activity is indispensable under excess ammonium conditions. Coincidently, its expression levels are maximal in the amastigote stage of the life cycle, when amino acids are preferably consumed, and NH4+ production is predictable. During host-cell invasion, TcGS is required for the parasite to escape from the parasitophorous vacuole, a process sine qua non for the parasite to replicate and establish infection in host cells. These results are the first to establish a link between the activity of a metabolic enzyme and the ability of a parasite to reach its intracellular niche to replicate and establish host-cell infection. Trypanosoma cruzi, the agent that causes Chagas disease, has a complex life cycle, alternating between insects and mammals and thus facing environments with different metabolite compositions. T. cruzi can consume glucose and/or amino acids, depending on their availability. However, amino acid consumption produces excess ammonium, which must be eliminated in a non-toxic manner. Here, we show that the enzyme glutamine synthetase contributes to the management of excess ammonium and uses it to form the amino acid glutamine. During its life cycle, the parasite invades mammalian host cells and transiently becomes enclosed in a tight vacuole, where it differentiates into the amastigote, an amino acid consumer stage. Amastigotes must escape from the vacuole into the host-cell cytoplasm to initiate intracellular replication. In this work, we show that the inhibition of T. cruzi glutamine synthetase aborts parasite evasion from the vacuole. We propose that this enzyme contributes to the control of ammonium produced by parasite metabolism, as ammonium increases the internal pH of the parasitophorous vacuole, making the enzymes for the T. cruzi evasion process non-functional. This knowledge could be useful for designing new anti-T. cruzi drugs.

11 January 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MMMarcelo L Merli
Marcelo L Merli
LPLucas Pagura
Lucas Pagura
JHJosefina Hernández
Josefina Hernández
MBMARIA JULIA BARISON
MARIA JULIA BARISON
EPElizabeth M F Pral
Elizabeth M F Pral
JCJulia Alejandra Cricco
Julia Alejandra Cricco
Trypanosoma cruzi, the etiological agent of Chagas' disease, presents nutritional requirements for several metabolites. It requires heme for the biosynthesis of several heme-proteins involved in essential metabolic pathways like mitochondrial cytochromes and respiratory complexes, as well as enzymes involved in the biosynthesis of sterols and unsaturated fatty acids. However, this parasite lacks a complete route for its synthesis. In view of these facts, T. cruzi has to incorporate heme from the environment during its life cycle. In other words, their hosts must supply the heme for heme-protein synthesis. Although the acquisition of heme is a fundamental issue for the parasite’s replication and survival, how this cofactor is imported and distributed is poorly understood. In this work, we used different fluorescent heme analogs to explore heme uptake along the different life-cycle stages of T. cruzi, showing that this parasite imports it during its replicative stages: the epimastigote in the insect vector and the intracellular amastigote in the mammalian host. Also, we identified and characterized a T. cruzi protein (TcHTE) with 55% of sequence similarity to LHR1 (protein involved in L. amazonensis heme transport), which is located in the flagellar pocket, where the transport of nutrients proceeds in trypanosomatids. We postulate TcHTE as a protein involved in improving the efficiency of the heme uptake or trafficking in T. cruzi. Trypanosoma cruzi is a protozoan parasite that causes Chagas’ disease, the most common parasitic disease in the Americas, but due to migration movements it has become relevant in non-endemic countries. T. cruzi, as other trypanosomatids responsible for human diseases (T. brucei and Leishmania spp.), lacks the enzymes for heme biosynthesis. However, it presents several heme-proteins involved in essential metabolic pathways, like biosynthesis of ergosterol and unsaturated fatty acids and mitochondrial cytochromes in its respiratory chain. In this work, we used different fluorescent compounds, which are structurally similar to heme (heme analogs), to explore the heme uptake in T. cruzi. The treatment of the different forms of T. cruzi with these compounds shows that this parasite is able to import heme during the replicative stages: epimastigote in the insect vector and intracellular amastigote in the mammalian host. We also characterized a T. cruzi protein, TcHTE, located in the flagellar pocket, where the transport of nutrients takes place in trypanosomatids. We propose TcHTE as a protein that improves the efficiency of the heme uptake. Considering the critical role of heme as an essential cofactor in T. cruzi, the identification of proteins involved in heme transport and distribution might result in the discovery of new molecular targets that may inhibit parasite proliferation.